A carregar...

Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials

Kappa-opioid receptor (KOR) antagonists are currently being considered for the treatment of a variety of neuropsychiatric conditions, including depressive, anxiety, and substance abuse disorders. A general ability to mitigate the effects of stress, which can trigger or exacerbate these conditions, m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Depress Anxiety
Main Authors: Carlezon, William A., Krystal, Andrew D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288841/
https://ncbi.nlm.nih.gov/pubmed/27699938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/da.22500
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!